Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.97 |
| ▸ | TK2 | O00142 | 2/20 | 0.68 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.64 |
| ▸ | P2RY14 | Q15391 | 3/20 | 0.64 |
| ▸ | TK1 | P04183 | 2/20 | 0.62 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.60 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.60 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.60 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.52 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18032577 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL2056544 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL3412420 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL2579194 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL12315567 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL3389861 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL2056540 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL654674 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL97336 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 | |
| SCHEMBL5165189 | 1.00 | PYGM (0.97) | PYGMTK2P2RY6P2RY14TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7349 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132391-A1 | Polynucleotides, Compositions, and Methods for Genome Editing | INTELLIA THERAPEUTICS, INC. (US) | 2026-05-14 | — | — | US | claimed |
| EP-4740010-A1 | NEGATIVE TUNE STANDARD FOR MASS SPECTROMETRY | Agilent Technologies, Inc. (US) | 2026-05-13 | — | — | EP | claimed |
| US-20260109727-A1 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2026-04-23 | — | — | US | claimed |
| US-20260078356-A1 | COMPOSITIONS AND METHODS FOR TREATING ORNITHINE TRANSCARBAMYLASE DEFICIENCY | ARCTURUS THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | claimed |
| US-12577554-B2 | Methods for purification of messenger RNA | TRANSLATE BIO, INC. (US) | 2026-03-17 | — | — | US | claimed |
| EP-4705468-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | California Institute of Technology (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569572-B2 | Messenger RNA therapy for the treatment of Friedreich's ataxia | TRANSLATE BIO, INC. (US) | 2026-03-10 | — | — | US | claimed |
| EP-4696703-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-02-18 | — | — | EP | claimed |
| US-20260028616-A1 | METHODS AND APPARATUS FOR DUPLEX NUCLEOTIDE PURIFICATION | AGILENT TECHNOLOGIES, INC. (US) | 2026-01-29 | — | — | US | claimed |
| EP-4676525-A2 | CORONAVIRUS VACCINES | DIOSynVax Ltd (GB) | 2026-01-14 | — | — | EP | claimed |
| EP-0702675-A4 | METHOD FOR PALLADIUM CATALYZED CARBON-CARBON COUPLING AND PRODUCTS | UNIV WASHINGTON (US) | 1996-02-02 | — | — | EP | claimed |
| EP-0673783-A2 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-5428149-A | Reacting vinyl and aryl stannanes with 2'-deoxy-5-halo-uridine | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1995-06-27 | — | — | US | claimed |
| WO-1994029279-A1 | METHOD FOR PALLADIUM CATALYZED CARBON-CARBON COUPLING AND PRODUCTS | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1994-12-22 | — | — | WO | claimed |
| EP-0366685-B1 | NUCLEOSIDE DERIVATIVES | FLOREY HOWARD INST (AU) | 1994-10-19 | — | — | EP | claimed |
| EP-0366685-A4 | NUCLEOSIDE DERIVATIVES | — | 1991-03-20 | — | — | EP | claimed |
| EP-0366685-A1 | NUCLEOSIDE DERIVATIVES. | FLOREY HOWARD INST (AU) | 1990-05-09 | — | — | EP | claimed |
| WO-1988010264-A1 | NUCLEOSIDE DERIVATIVES | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY (AU) | 1988-12-29 | — | — | WO | claimed |
| US-4529700-A | Hybridoma cells secreting a monoclonal antibody specific for 5-bromo and 5-iodoeoxyuridine and reagents for measuring cellular proliferation | UNIVERSITY OF MIAMI (US) | 1985-07-16 | — | — | US | claimed |
| EP-0102228-A2 | Hybridoma secreting a monoclonal antibody specific for 5-bromo and 5-iododeoxyuridine and reagent for measuring cellular proliferation | UNIVERSITY OF MIAMI (US) | 1984-03-07 | — | — | EP | claimed |